is semaglutide or tirzepatide safer Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide and semaglutide, the ingredients

This comparison requires major caveats, since GLP-1 medications are not approved for endometriosis and the evidence base is incomparable

GLP1 receptor agonists and related mental health issues

The most common side effects are mild and may include slight irritation at the injection site or a temporary metallic taste in the mouth

Initial clinical trials have shown remarkable results, with several of these agents demonstrating unprecedented weight reduction and improvements in blood glycemic control

The molecule itself is the same whether it comes in a Novo Nordisk pen or a vial prepared by a compounding pharmacy

Labs: Not included in membership, but Mochi can facilitate discounted lab ordering for patients paying out of pocket